DDX23, as a substrate protein, was reported to interact with SDC4 with the aid of bufalin, a small molecule anticancer drug, to induce inactivated matrix metalloproteinases and elevated p38/JNK MAPKs phosphorylation in hepatocellular carcinoma [23]. Here, MAPK8 is linked to hepatocellular carcinoma.